Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering
Lantern Pharma closed a registered direct offering of 3,669,725 shares at $1.09 per share, raising approximately $4 million in gross proceeds. In a concurrent private placement, the company issued unregistered warrants for up to another 3,669,725 shares at the same $1.09 exercise price, which could add roughly $4 million if fully exercised — contingent on stockholder approval of the underlying shares.
Key figures
- Deal Value Usd
- 4000000
- Offering Price
- 1.09
- Shares Offered
- 3669725
- Warrant shares
- 3669725
- Warrant exercise price
- 1.09
- Potential warrant proceeds
- 4000000
- Total potential gross proceeds
- 8000000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.